Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05844176
Other study ID # ICAS-Young
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2022
Est. completion date October 1, 2024

Study information

Verified date August 2023
Source Capital Medical University
Contact Xunming Ji, MD
Phone 010-83199439
Email jixm@ccmu.edu.cn
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The goal of this study is to evaluate the characteristic of intracranial arterial stenosis among young patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date October 1, 2024
Est. primary completion date October 1, 2023
Accepts healthy volunteers No
Gender All
Age group N/A to 45 Years
Eligibility Inclusion Criteria: - age < 45 years. - stenosis of a major intracranial artery. Exclusion Criteria: -

Study Design


Intervention

Other:
Routine clinical treatment
Routine clinical treatment is based on the latest international and local guidelines

Locations

Country Name City State
China Xuanwu Hospital, Capital Medical University Beijing
China The Second Hospital of Hebei Medical University Shijiazhuang Hebei
China Suzhou Municipal Hoapital Suzhou An Hui
China The First Affiliated Hospital of Zhengzhou University Zhengzhou

Sponsors (1)

Lead Sponsor Collaborator
Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ischemic stroke in territory of qualifying artery 1 year
Secondary Ischemic stroke in other territory 1 year
Secondary Any stroke 1 year
Secondary Death 1 year
Secondary Stenosis of the intracranial artery 1 year
See also
  Status Clinical Trial Phase
Completed NCT01819597 - Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis N/A
Enrolling by invitation NCT04240119 - Angiogenic Markers in Cerebrovascular Disease (ANFIS)
Recruiting NCT01553643 - A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis Phase 4
Completed NCT01570231 - Feasibility, Safety and Efficacy of Remote Ischemic Preconditioning for Symptomatic Intracranial Arterial Stenosis in Octogenarians Phase 1
Completed NCT02041117 - Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging Phase 4